nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—CYP3A5—Clonidine—glaucoma	0.0517	0.172	CbGbCtD
Sirolimus—CYP3A4—Pilocarpine—glaucoma	0.0413	0.137	CbGbCtD
Sirolimus—ABCB1—Timolol—glaucoma	0.0396	0.132	CbGbCtD
Sirolimus—ABCB1—Clonidine—glaucoma	0.0336	0.112	CbGbCtD
Sirolimus—CYP3A4—Brinzolamide—glaucoma	0.0324	0.108	CbGbCtD
Sirolimus—CYP3A4—Dorzolamide—glaucoma	0.0313	0.104	CbGbCtD
Sirolimus—CYP3A4—Methazolamide—glaucoma	0.0279	0.0929	CbGbCtD
Sirolimus—CYP3A4—Acetazolamide—glaucoma	0.0223	0.0742	CbGbCtD
Sirolimus—CYP3A4—Clonidine—glaucoma	0.0202	0.0671	CbGbCtD
Sirolimus—Agitation—Clonidine—glaucoma	0.000265	0.000604	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000265	0.000604	CcSEcCtD
Sirolimus—Paraesthesia—Pilocarpine—glaucoma	0.000265	0.000603	CcSEcCtD
Sirolimus—Asthenia—Bimatoprost—glaucoma	0.000265	0.000603	CcSEcCtD
Sirolimus—Angioedema—Clonidine—glaucoma	0.000264	0.000601	CcSEcCtD
Sirolimus—Dyspnoea—Pilocarpine—glaucoma	0.000263	0.000599	CcSEcCtD
Sirolimus—Pain—Brinzolamide—glaucoma	0.000263	0.000598	CcSEcCtD
Sirolimus—Somnolence—Pilocarpine—glaucoma	0.000262	0.000597	CcSEcCtD
Sirolimus—Angiopathy—Betaxolol—glaucoma	0.000262	0.000597	CcSEcCtD
Sirolimus—Pruritus—Bimatoprost—glaucoma	0.000261	0.000595	CcSEcCtD
Sirolimus—Immune system disorder—Betaxolol—glaucoma	0.000261	0.000594	CcSEcCtD
Sirolimus—Diarrhoea—Apraclonidine—glaucoma	0.000261	0.000593	CcSEcCtD
Sirolimus—Malaise—Clonidine—glaucoma	0.000261	0.000593	CcSEcCtD
Sirolimus—Mediastinal disorder—Betaxolol—glaucoma	0.00026	0.000593	CcSEcCtD
Sirolimus—Dyspepsia—Pilocarpine—glaucoma	0.00026	0.000591	CcSEcCtD
Sirolimus—Chills—Betaxolol—glaucoma	0.000259	0.00059	CcSEcCtD
Sirolimus—Syncope—Clonidine—glaucoma	0.000259	0.00059	CcSEcCtD
Sirolimus—Feeling abnormal—Dorzolamide—glaucoma	0.000257	0.000586	CcSEcCtD
Sirolimus—Decreased appetite—Pilocarpine—glaucoma	0.000257	0.000584	CcSEcCtD
Sirolimus—Feeling abnormal—Travoprost—glaucoma	0.000256	0.000583	CcSEcCtD
Sirolimus—Conjunctivitis—Timolol—glaucoma	0.000256	0.000582	CcSEcCtD
Sirolimus—Gastrointestinal pain—Dorzolamide—glaucoma	0.000255	0.000582	CcSEcCtD
Sirolimus—Palpitations—Clonidine—glaucoma	0.000255	0.000581	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000255	0.00058	CcSEcCtD
Sirolimus—Gastrointestinal pain—Travoprost—glaucoma	0.000254	0.000579	CcSEcCtD
Sirolimus—Loss of consciousness—Clonidine—glaucoma	0.000254	0.000578	CcSEcCtD
Sirolimus—Feeling abnormal—Brinzolamide—glaucoma	0.000253	0.000576	CcSEcCtD
Sirolimus—Constipation—Pilocarpine—glaucoma	0.000252	0.000575	CcSEcCtD
Sirolimus—Pain—Pilocarpine—glaucoma	0.000252	0.000575	CcSEcCtD
Sirolimus—Cough—Clonidine—glaucoma	0.000252	0.000574	CcSEcCtD
Sirolimus—Sweating—Timolol—glaucoma	0.000252	0.000574	CcSEcCtD
Sirolimus—Dizziness—Apraclonidine—glaucoma	0.000252	0.000574	CcSEcCtD
Sirolimus—Malnutrition—Betaxolol—glaucoma	0.000252	0.000572	CcSEcCtD
Sirolimus—Epistaxis—Timolol—glaucoma	0.000248	0.000564	CcSEcCtD
Sirolimus—Abdominal pain—Dorzolamide—glaucoma	0.000247	0.000562	CcSEcCtD
Sirolimus—Body temperature increased—Dorzolamide—glaucoma	0.000247	0.000562	CcSEcCtD
Sirolimus—Tension—Betaxolol—glaucoma	0.000247	0.000562	CcSEcCtD
Sirolimus—Sinusitis—Timolol—glaucoma	0.000247	0.000561	CcSEcCtD
Sirolimus—Arthralgia—Clonidine—glaucoma	0.000246	0.00056	CcSEcCtD
Sirolimus—Chest pain—Clonidine—glaucoma	0.000246	0.00056	CcSEcCtD
Sirolimus—Abdominal pain—Travoprost—glaucoma	0.000246	0.00056	CcSEcCtD
Sirolimus—Anxiety—Clonidine—glaucoma	0.000245	0.000558	CcSEcCtD
Sirolimus—Asthenia—Acetazolamide—glaucoma	0.000245	0.000557	CcSEcCtD
Sirolimus—Dizziness—Bimatoprost—glaucoma	0.000244	0.000556	CcSEcCtD
Sirolimus—Nervousness—Betaxolol—glaucoma	0.000244	0.000556	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000244	0.000556	CcSEcCtD
Sirolimus—Feeling abnormal—Pilocarpine—glaucoma	0.000243	0.000554	CcSEcCtD
Sirolimus—Discomfort—Clonidine—glaucoma	0.000243	0.000553	CcSEcCtD
Sirolimus—Vomiting—Apraclonidine—glaucoma	0.000242	0.000551	CcSEcCtD
Sirolimus—Muscle spasms—Betaxolol—glaucoma	0.000242	0.00055	CcSEcCtD
Sirolimus—Gastrointestinal pain—Pilocarpine—glaucoma	0.000241	0.000549	CcSEcCtD
Sirolimus—Hypersensitivity—Brimonidine—glaucoma	0.000241	0.000549	CcSEcCtD
Sirolimus—Dermatitis—Apraclonidine—glaucoma	0.00024	0.000546	CcSEcCtD
Sirolimus—Headache—Apraclonidine—glaucoma	0.000239	0.000543	CcSEcCtD
Sirolimus—Confusional state—Clonidine—glaucoma	0.000238	0.000541	CcSEcCtD
Sirolimus—Rhinitis—Timolol—glaucoma	0.000237	0.000539	CcSEcCtD
Sirolimus—Oedema—Clonidine—glaucoma	0.000236	0.000537	CcSEcCtD
Sirolimus—Tremor—Betaxolol—glaucoma	0.000236	0.000536	CcSEcCtD
Sirolimus—Hallucination—Timolol—glaucoma	0.000235	0.000534	CcSEcCtD
Sirolimus—Asthenia—Brimonidine—glaucoma	0.000235	0.000534	CcSEcCtD
Sirolimus—Infection—Clonidine—glaucoma	0.000234	0.000533	CcSEcCtD
Sirolimus—Abdominal pain—Pilocarpine—glaucoma	0.000233	0.000531	CcSEcCtD
Sirolimus—Body temperature increased—Pilocarpine—glaucoma	0.000233	0.000531	CcSEcCtD
Sirolimus—Ill-defined disorder—Betaxolol—glaucoma	0.000233	0.000531	CcSEcCtD
Sirolimus—Diarrhoea—Acetazolamide—glaucoma	0.000233	0.000531	CcSEcCtD
Sirolimus—Rash—Bimatoprost—glaucoma	0.000233	0.00053	CcSEcCtD
Sirolimus—Dermatitis—Bimatoprost—glaucoma	0.000233	0.00053	CcSEcCtD
Sirolimus—Oedema peripheral—Timolol—glaucoma	0.000233	0.000529	CcSEcCtD
Sirolimus—Anaemia—Betaxolol—glaucoma	0.000232	0.000529	CcSEcCtD
Sirolimus—Shock—Clonidine—glaucoma	0.000232	0.000528	CcSEcCtD
Sirolimus—Connective tissue disorder—Timolol—glaucoma	0.000232	0.000528	CcSEcCtD
Sirolimus—Pruritus—Brimonidine—glaucoma	0.000231	0.000527	CcSEcCtD
Sirolimus—Headache—Bimatoprost—glaucoma	0.000231	0.000527	CcSEcCtD
Sirolimus—Nervous system disorder—Clonidine—glaucoma	0.000231	0.000526	CcSEcCtD
Sirolimus—Thrombocytopenia—Clonidine—glaucoma	0.000231	0.000525	CcSEcCtD
Sirolimus—Hypersensitivity—Dorzolamide—glaucoma	0.00023	0.000524	CcSEcCtD
Sirolimus—Tachycardia—Clonidine—glaucoma	0.00023	0.000524	CcSEcCtD
Sirolimus—Hypersensitivity—Travoprost—glaucoma	0.000229	0.000522	CcSEcCtD
Sirolimus—Skin disorder—Clonidine—glaucoma	0.000229	0.000521	CcSEcCtD
Sirolimus—Hyperhidrosis—Clonidine—glaucoma	0.000228	0.000519	CcSEcCtD
Sirolimus—Visual impairment—Timolol—glaucoma	0.000227	0.000518	CcSEcCtD
Sirolimus—Malaise—Betaxolol—glaucoma	0.000227	0.000516	CcSEcCtD
Sirolimus—Nausea—Apraclonidine—glaucoma	0.000226	0.000515	CcSEcCtD
Sirolimus—Hypersensitivity—Brinzolamide—glaucoma	0.000226	0.000515	CcSEcCtD
Sirolimus—Syncope—Betaxolol—glaucoma	0.000226	0.000513	CcSEcCtD
Sirolimus—Dizziness—Acetazolamide—glaucoma	0.000225	0.000513	CcSEcCtD
Sirolimus—Anorexia—Clonidine—glaucoma	0.000225	0.000512	CcSEcCtD
Sirolimus—Asthenia—Dorzolamide—glaucoma	0.000224	0.00051	CcSEcCtD
Sirolimus—Asthenia—Travoprost—glaucoma	0.000223	0.000508	CcSEcCtD
Sirolimus—Palpitations—Betaxolol—glaucoma	0.000222	0.000506	CcSEcCtD
Sirolimus—Pruritus—Dorzolamide—glaucoma	0.000221	0.000503	CcSEcCtD
Sirolimus—Loss of consciousness—Betaxolol—glaucoma	0.000221	0.000503	CcSEcCtD
Sirolimus—Asthenia—Brinzolamide—glaucoma	0.00022	0.000502	CcSEcCtD
Sirolimus—Hypotension—Clonidine—glaucoma	0.00022	0.000501	CcSEcCtD
Sirolimus—Pruritus—Travoprost—glaucoma	0.00022	0.000501	CcSEcCtD
Sirolimus—Tinnitus—Timolol—glaucoma	0.00022	0.000501	CcSEcCtD
Sirolimus—Cough—Betaxolol—glaucoma	0.000219	0.0005	CcSEcCtD
Sirolimus—Nausea—Bimatoprost—glaucoma	0.000219	0.0005	CcSEcCtD
Sirolimus—Cardiac disorder—Timolol—glaucoma	0.000219	0.000499	CcSEcCtD
Sirolimus—Hypersensitivity—Pilocarpine—glaucoma	0.000218	0.000495	CcSEcCtD
Sirolimus—Pruritus—Brinzolamide—glaucoma	0.000217	0.000495	CcSEcCtD
Sirolimus—Vomiting—Acetazolamide—glaucoma	0.000217	0.000493	CcSEcCtD
Sirolimus—Dizziness—Brimonidine—glaucoma	0.000216	0.000492	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Clonidine—glaucoma	0.000215	0.000489	CcSEcCtD
Sirolimus—Angiopathy—Timolol—glaucoma	0.000214	0.000487	CcSEcCtD
Sirolimus—Arthralgia—Betaxolol—glaucoma	0.000214	0.000487	CcSEcCtD
Sirolimus—Chest pain—Betaxolol—glaucoma	0.000214	0.000487	CcSEcCtD
Sirolimus—Myalgia—Betaxolol—glaucoma	0.000214	0.000487	CcSEcCtD
Sirolimus—Diarrhoea—Dorzolamide—glaucoma	0.000214	0.000487	CcSEcCtD
Sirolimus—Headache—Acetazolamide—glaucoma	0.000214	0.000486	CcSEcCtD
Sirolimus—Anxiety—Betaxolol—glaucoma	0.000213	0.000486	CcSEcCtD
Sirolimus—Insomnia—Clonidine—glaucoma	0.000213	0.000485	CcSEcCtD
Sirolimus—Immune system disorder—Timolol—glaucoma	0.000213	0.000485	CcSEcCtD
Sirolimus—Diarrhoea—Travoprost—glaucoma	0.000213	0.000484	CcSEcCtD
Sirolimus—Mediastinal disorder—Timolol—glaucoma	0.000213	0.000484	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000213	0.000484	CcSEcCtD
Sirolimus—Asthenia—Pilocarpine—glaucoma	0.000212	0.000482	CcSEcCtD
Sirolimus—Paraesthesia—Clonidine—glaucoma	0.000212	0.000482	CcSEcCtD
Sirolimus—Discomfort—Betaxolol—glaucoma	0.000212	0.000481	CcSEcCtD
Sirolimus—Dyspnoea—Clonidine—glaucoma	0.00021	0.000478	CcSEcCtD
Sirolimus—Diarrhoea—Brinzolamide—glaucoma	0.00021	0.000478	CcSEcCtD
Sirolimus—Somnolence—Clonidine—glaucoma	0.00021	0.000477	CcSEcCtD
Sirolimus—Pruritus—Pilocarpine—glaucoma	0.000209	0.000475	CcSEcCtD
Sirolimus—Confusional state—Betaxolol—glaucoma	0.000207	0.000471	CcSEcCtD
Sirolimus—Dizziness—Dorzolamide—glaucoma	0.000207	0.00047	CcSEcCtD
Sirolimus—Rash—Brimonidine—glaucoma	0.000206	0.000469	CcSEcCtD
Sirolimus—Dermatitis—Brimonidine—glaucoma	0.000206	0.000469	CcSEcCtD
Sirolimus—Dizziness—Travoprost—glaucoma	0.000206	0.000468	CcSEcCtD
Sirolimus—Malnutrition—Timolol—glaucoma	0.000205	0.000468	CcSEcCtD
Sirolimus—Oedema—Betaxolol—glaucoma	0.000205	0.000467	CcSEcCtD
Sirolimus—Headache—Brimonidine—glaucoma	0.000205	0.000466	CcSEcCtD
Sirolimus—Decreased appetite—Clonidine—glaucoma	0.000205	0.000466	CcSEcCtD
Sirolimus—Infection—Betaxolol—glaucoma	0.000204	0.000464	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Clonidine—glaucoma	0.000204	0.000463	CcSEcCtD
Sirolimus—Dizziness—Brinzolamide—glaucoma	0.000203	0.000462	CcSEcCtD
Sirolimus—Nausea—Acetazolamide—glaucoma	0.000202	0.000461	CcSEcCtD
Sirolimus—Diarrhoea—Pilocarpine—glaucoma	0.000202	0.00046	CcSEcCtD
Sirolimus—Shock—Betaxolol—glaucoma	0.000202	0.00046	CcSEcCtD
Sirolimus—Tension—Timolol—glaucoma	0.000202	0.000459	CcSEcCtD
Sirolimus—Pain—Clonidine—glaucoma	0.000202	0.000459	CcSEcCtD
Sirolimus—Constipation—Clonidine—glaucoma	0.000202	0.000459	CcSEcCtD
Sirolimus—Nervous system disorder—Betaxolol—glaucoma	0.000201	0.000458	CcSEcCtD
Sirolimus—Thrombocytopenia—Betaxolol—glaucoma	0.000201	0.000457	CcSEcCtD
Sirolimus—Tachycardia—Betaxolol—glaucoma	0.0002	0.000456	CcSEcCtD
Sirolimus—Nervousness—Timolol—glaucoma	0.0002	0.000454	CcSEcCtD
Sirolimus—Skin disorder—Betaxolol—glaucoma	0.000199	0.000454	CcSEcCtD
Sirolimus—Vomiting—Dorzolamide—glaucoma	0.000199	0.000452	CcSEcCtD
Sirolimus—Hyperhidrosis—Betaxolol—glaucoma	0.000198	0.000452	CcSEcCtD
Sirolimus—Rash—Dorzolamide—glaucoma	0.000197	0.000448	CcSEcCtD
Sirolimus—Dermatitis—Dorzolamide—glaucoma	0.000197	0.000448	CcSEcCtD
Sirolimus—Rash—Travoprost—glaucoma	0.000196	0.000446	CcSEcCtD
Sirolimus—Dermatitis—Travoprost—glaucoma	0.000196	0.000446	CcSEcCtD
Sirolimus—Headache—Dorzolamide—glaucoma	0.000196	0.000445	CcSEcCtD
Sirolimus—Anorexia—Betaxolol—glaucoma	0.000196	0.000445	CcSEcCtD
Sirolimus—Vomiting—Brinzolamide—glaucoma	0.000195	0.000445	CcSEcCtD
Sirolimus—Dizziness—Pilocarpine—glaucoma	0.000195	0.000444	CcSEcCtD
Sirolimus—Headache—Travoprost—glaucoma	0.000195	0.000444	CcSEcCtD
Sirolimus—Nausea—Brimonidine—glaucoma	0.000194	0.000442	CcSEcCtD
Sirolimus—Feeling abnormal—Clonidine—glaucoma	0.000194	0.000442	CcSEcCtD
Sirolimus—Rash—Brinzolamide—glaucoma	0.000194	0.000441	CcSEcCtD
Sirolimus—Dermatitis—Brinzolamide—glaucoma	0.000194	0.00044	CcSEcCtD
Sirolimus—Gastrointestinal pain—Clonidine—glaucoma	0.000193	0.000439	CcSEcCtD
Sirolimus—Headache—Brinzolamide—glaucoma	0.000192	0.000438	CcSEcCtD
Sirolimus—Hypotension—Betaxolol—glaucoma	0.000192	0.000437	CcSEcCtD
Sirolimus—Angioedema—Timolol—glaucoma	0.000188	0.000427	CcSEcCtD
Sirolimus—Vomiting—Pilocarpine—glaucoma	0.000188	0.000427	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000187	0.000426	CcSEcCtD
Sirolimus—Abdominal pain—Clonidine—glaucoma	0.000186	0.000424	CcSEcCtD
Sirolimus—Body temperature increased—Clonidine—glaucoma	0.000186	0.000424	CcSEcCtD
Sirolimus—Rash—Pilocarpine—glaucoma	0.000186	0.000424	CcSEcCtD
Sirolimus—Dermatitis—Pilocarpine—glaucoma	0.000186	0.000423	CcSEcCtD
Sirolimus—Insomnia—Betaxolol—glaucoma	0.000186	0.000423	CcSEcCtD
Sirolimus—Nausea—Dorzolamide—glaucoma	0.000186	0.000422	CcSEcCtD
Sirolimus—Headache—Pilocarpine—glaucoma	0.000185	0.000421	CcSEcCtD
Sirolimus—Nausea—Travoprost—glaucoma	0.000185	0.000421	CcSEcCtD
Sirolimus—Paraesthesia—Betaxolol—glaucoma	0.000184	0.000419	CcSEcCtD
Sirolimus—Syncope—Timolol—glaucoma	0.000184	0.000419	CcSEcCtD
Sirolimus—Dyspnoea—Betaxolol—glaucoma	0.000183	0.000417	CcSEcCtD
Sirolimus—Nausea—Brinzolamide—glaucoma	0.000182	0.000415	CcSEcCtD
Sirolimus—Palpitations—Timolol—glaucoma	0.000182	0.000413	CcSEcCtD
Sirolimus—Dyspepsia—Betaxolol—glaucoma	0.000181	0.000411	CcSEcCtD
Sirolimus—Loss of consciousness—Timolol—glaucoma	0.000181	0.000411	CcSEcCtD
Sirolimus—Cough—Timolol—glaucoma	0.000179	0.000408	CcSEcCtD
Sirolimus—Decreased appetite—Betaxolol—glaucoma	0.000178	0.000406	CcSEcCtD
Sirolimus—Hypertension—Timolol—glaucoma	0.000177	0.000404	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Betaxolol—glaucoma	0.000177	0.000403	CcSEcCtD
Sirolimus—Pain—Betaxolol—glaucoma	0.000176	0.0004	CcSEcCtD
Sirolimus—Constipation—Betaxolol—glaucoma	0.000176	0.0004	CcSEcCtD
Sirolimus—Nausea—Pilocarpine—glaucoma	0.000175	0.000399	CcSEcCtD
Sirolimus—Chest pain—Timolol—glaucoma	0.000175	0.000398	CcSEcCtD
Sirolimus—Arthralgia—Timolol—glaucoma	0.000175	0.000398	CcSEcCtD
Sirolimus—Myalgia—Timolol—glaucoma	0.000175	0.000398	CcSEcCtD
Sirolimus—Anxiety—Timolol—glaucoma	0.000174	0.000397	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000174	0.000395	CcSEcCtD
Sirolimus—Hypersensitivity—Clonidine—glaucoma	0.000174	0.000395	CcSEcCtD
Sirolimus—Discomfort—Timolol—glaucoma	0.000173	0.000393	CcSEcCtD
Sirolimus—Asthenia—Clonidine—glaucoma	0.000169	0.000385	CcSEcCtD
Sirolimus—Feeling abnormal—Betaxolol—glaucoma	0.000169	0.000385	CcSEcCtD
Sirolimus—Confusional state—Timolol—glaucoma	0.000169	0.000385	CcSEcCtD
Sirolimus—Anaphylactic shock—Timolol—glaucoma	0.000168	0.000382	CcSEcCtD
Sirolimus—Oedema—Timolol—glaucoma	0.000168	0.000382	CcSEcCtD
Sirolimus—Pruritus—Clonidine—glaucoma	0.000167	0.00038	CcSEcCtD
Sirolimus—Infection—Timolol—glaucoma	0.000167	0.000379	CcSEcCtD
Sirolimus—Shock—Timolol—glaucoma	0.000165	0.000375	CcSEcCtD
Sirolimus—Nervous system disorder—Timolol—glaucoma	0.000164	0.000374	CcSEcCtD
Sirolimus—Skin disorder—Timolol—glaucoma	0.000163	0.000371	CcSEcCtD
Sirolimus—Body temperature increased—Betaxolol—glaucoma	0.000162	0.000369	CcSEcCtD
Sirolimus—Hyperhidrosis—Timolol—glaucoma	0.000162	0.000369	CcSEcCtD
Sirolimus—Diarrhoea—Clonidine—glaucoma	0.000161	0.000367	CcSEcCtD
Sirolimus—Anorexia—Timolol—glaucoma	0.00016	0.000364	CcSEcCtD
Sirolimus—Hypotension—Timolol—glaucoma	0.000157	0.000357	CcSEcCtD
Sirolimus—Dizziness—Clonidine—glaucoma	0.000156	0.000355	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Timolol—glaucoma	0.000153	0.000348	CcSEcCtD
Sirolimus—Insomnia—Timolol—glaucoma	0.000152	0.000345	CcSEcCtD
Sirolimus—Hypersensitivity—Betaxolol—glaucoma	0.000151	0.000344	CcSEcCtD
Sirolimus—Paraesthesia—Timolol—glaucoma	0.000151	0.000343	CcSEcCtD
Sirolimus—Vomiting—Clonidine—glaucoma	0.00015	0.000341	CcSEcCtD
Sirolimus—Dyspnoea—Timolol—glaucoma	0.00015	0.00034	CcSEcCtD
Sirolimus—Somnolence—Timolol—glaucoma	0.000149	0.000339	CcSEcCtD
Sirolimus—Rash—Clonidine—glaucoma	0.000149	0.000338	CcSEcCtD
Sirolimus—Dermatitis—Clonidine—glaucoma	0.000149	0.000338	CcSEcCtD
Sirolimus—Headache—Clonidine—glaucoma	0.000148	0.000336	CcSEcCtD
Sirolimus—Dyspepsia—Timolol—glaucoma	0.000148	0.000336	CcSEcCtD
Sirolimus—Asthenia—Betaxolol—glaucoma	0.000147	0.000335	CcSEcCtD
Sirolimus—Decreased appetite—Timolol—glaucoma	0.000146	0.000332	CcSEcCtD
Sirolimus—Pruritus—Betaxolol—glaucoma	0.000145	0.000331	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Timolol—glaucoma	0.000145	0.000329	CcSEcCtD
Sirolimus—Pain—Timolol—glaucoma	0.000143	0.000326	CcSEcCtD
Sirolimus—Diarrhoea—Betaxolol—glaucoma	0.00014	0.00032	CcSEcCtD
Sirolimus—Nausea—Clonidine—glaucoma	0.00014	0.000319	CcSEcCtD
Sirolimus—Feeling abnormal—Timolol—glaucoma	0.000138	0.000315	CcSEcCtD
Sirolimus—Gastrointestinal pain—Timolol—glaucoma	0.000137	0.000312	CcSEcCtD
Sirolimus—Dizziness—Betaxolol—glaucoma	0.000136	0.000309	CcSEcCtD
Sirolimus—Abdominal pain—Timolol—glaucoma	0.000133	0.000302	CcSEcCtD
Sirolimus—Body temperature increased—Timolol—glaucoma	0.000133	0.000302	CcSEcCtD
Sirolimus—Vomiting—Betaxolol—glaucoma	0.000131	0.000297	CcSEcCtD
Sirolimus—Rash—Betaxolol—glaucoma	0.000129	0.000295	CcSEcCtD
Sirolimus—Dermatitis—Betaxolol—glaucoma	0.000129	0.000294	CcSEcCtD
Sirolimus—Headache—Betaxolol—glaucoma	0.000129	0.000293	CcSEcCtD
Sirolimus—EIF4E—connective tissue—glaucoma	0.000125	0.234	CbGeAlD
Sirolimus—Hypersensitivity—Timolol—glaucoma	0.000124	0.000281	CcSEcCtD
Sirolimus—Nausea—Betaxolol—glaucoma	0.000122	0.000277	CcSEcCtD
Sirolimus—Asthenia—Timolol—glaucoma	0.00012	0.000274	CcSEcCtD
Sirolimus—Pruritus—Timolol—glaucoma	0.000119	0.00027	CcSEcCtD
Sirolimus—Diarrhoea—Timolol—glaucoma	0.000115	0.000261	CcSEcCtD
Sirolimus—Dizziness—Timolol—glaucoma	0.000111	0.000252	CcSEcCtD
Sirolimus—Vomiting—Timolol—glaucoma	0.000107	0.000243	CcSEcCtD
Sirolimus—Rash—Timolol—glaucoma	0.000106	0.000241	CcSEcCtD
Sirolimus—Dermatitis—Timolol—glaucoma	0.000106	0.00024	CcSEcCtD
Sirolimus—Headache—Timolol—glaucoma	0.000105	0.000239	CcSEcCtD
Sirolimus—Nausea—Timolol—glaucoma	9.96e-05	0.000227	CcSEcCtD
Sirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—CDKN1B—glaucoma	9.58e-05	0.000368	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR—CDKN1B—glaucoma	9.49e-05	0.000365	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR in Cancer—CDKN1B—glaucoma	9.41e-05	0.000362	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—BAD—glaucoma	9.37e-05	0.00036	CbGpPWpGaD
Sirolimus—MTOR—Signaling by PDGF—CDKN1B—glaucoma	9.37e-05	0.00036	CbGpPWpGaD
Sirolimus—MTOR—Immune System—C1QB—glaucoma	9.22e-05	0.000355	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—HDAC9—glaucoma	9.15e-05	0.000352	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—TP53—glaucoma	9.14e-05	0.000352	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—NR3C1—glaucoma	9.05e-05	0.000348	CbGpPWpGaD
Sirolimus—MTOR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	9.04e-05	0.000348	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—NTRK2—glaucoma	8.93e-05	0.000344	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—OPN4—glaucoma	8.87e-05	0.000341	CbGpPWpGaD
Sirolimus—MTOR—B Cell Activation—CDKN1B—glaucoma	8.86e-05	0.000341	CbGpPWpGaD
Sirolimus—FGF2—Signaling by NGF—CDKN1B—glaucoma	8.79e-05	0.000338	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—C3—glaucoma	8.7e-05	0.000335	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CA5A—glaucoma	8.69e-05	0.000334	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—NARFL—glaucoma	8.69e-05	0.000334	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—MMP9—glaucoma	8.68e-05	0.000334	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	8.66e-05	0.000333	CbGpPWpGaD
Sirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	8.48e-05	0.000326	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CA1—glaucoma	8.48e-05	0.000326	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—RPTOR—glaucoma	8.42e-05	0.000324	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—BCL2L1—glaucoma	8.32e-05	0.00032	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	8.31e-05	0.00032	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—C3—glaucoma	8.3e-05	0.000319	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—HEYL—glaucoma	8.25e-05	0.000317	CbGpPWpGaD
Sirolimus—MTOR—Immune System—TXN—glaucoma	8.22e-05	0.000316	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CTSA—glaucoma	8.21e-05	0.000316	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NCK2—glaucoma	8.16e-05	0.000314	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PTGFR—glaucoma	7.99e-05	0.000307	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—C3—glaucoma	7.97e-05	0.000307	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—BCL2L1—glaucoma	7.94e-05	0.000306	CbGpPWpGaD
Sirolimus—FGF2—eye—glaucoma	7.89e-05	0.148	CbGeAlD
Sirolimus—MTOR—Cellular responses to stress—CDKN2A—glaucoma	7.85e-05	0.000302	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CA1—glaucoma	7.78e-05	0.000299	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CA2—glaucoma	7.76e-05	0.000298	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	7.66e-05	0.000295	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—NGFR—glaucoma	7.66e-05	0.000295	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—GSTT1—glaucoma	7.64e-05	0.000294	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	7.63e-05	0.000294	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	7.61e-05	0.000293	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.58e-05	0.000292	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.58e-05	0.000292	CbGpPWpGaD
Sirolimus—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	7.55e-05	0.00029	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—BAD—glaucoma	7.54e-05	0.00029	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CTSA—glaucoma	7.54e-05	0.00029	CbGpPWpGaD
Sirolimus—MTOR—Disease—HDAC9—glaucoma	7.35e-05	0.000283	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—NTRK1—glaucoma	7.28e-05	0.00028	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—BAD—glaucoma	7.2e-05	0.000277	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—SMO—glaucoma	7.16e-05	0.000275	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CA2—glaucoma	7.12e-05	0.000274	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.11e-05	0.000274	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—CDKN2B—glaucoma	7.03e-05	0.00027	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—MMP2—glaucoma	7e-05	0.000269	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—CDKN1B—glaucoma	6.96e-05	0.000268	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—HDAC9—glaucoma	6.93e-05	0.000267	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—BAD—glaucoma	6.91e-05	0.000266	CbGpPWpGaD
Sirolimus—MTOR—Integrated Breast Cancer Pathway—TP53—glaucoma	6.83e-05	0.000263	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CDKN2B—glaucoma	6.71e-05	0.000258	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NTRK2—glaucoma	6.55e-05	0.000252	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—VEGFA—glaucoma	6.54e-05	0.000252	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—CDKN1B—glaucoma	6.52e-05	0.000251	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	6.51e-05	0.000251	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—EDN1—glaucoma	6.44e-05	0.000248	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—RPTOR—glaucoma	6.25e-05	0.00024	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—C3—glaucoma	6.16e-05	0.000237	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—CYP1B1—glaucoma	6.09e-05	0.000234	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NCK2—glaucoma	6.05e-05	0.000233	CbGpPWpGaD
Sirolimus—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	6.01e-05	0.000231	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—C3—glaucoma	5.91e-05	0.000228	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—NGF—glaucoma	5.91e-05	0.000228	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—BCL2L1—glaucoma	5.9e-05	0.000227	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—MTHFR—glaucoma	5.89e-05	0.000227	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—VEGFA—glaucoma	5.78e-05	0.000223	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CA1—glaucoma	5.63e-05	0.000216	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—C3—glaucoma	5.62e-05	0.000216	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NGFR—glaucoma	5.62e-05	0.000216	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—TNF—glaucoma	5.6e-05	0.000216	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	5.57e-05	0.000214	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL1A—glaucoma	5.5e-05	0.000212	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—APOE—glaucoma	5.48e-05	0.000211	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—TXN—glaucoma	5.46e-05	0.00021	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CTSA—glaucoma	5.45e-05	0.00021	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—CAV1—glaucoma	5.43e-05	0.000209	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—SMO—glaucoma	5.43e-05	0.000209	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—NARFL—glaucoma	5.36e-05	0.000206	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CA5A—glaucoma	5.36e-05	0.000206	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—BAD—glaucoma	5.34e-05	0.000206	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NTRK1—glaucoma	5.34e-05	0.000205	CbGpPWpGaD
Sirolimus—FGF2—Disease—CDKN2B—glaucoma	5.32e-05	0.000205	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—MMP9—glaucoma	5.26e-05	0.000202	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CDKN1B—glaucoma	5.25e-05	0.000202	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—APOE—glaucoma	5.23e-05	0.000201	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.21e-05	0.0002	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CAV1—glaucoma	5.19e-05	0.0002	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—HDAC9—glaucoma	5.15e-05	0.000198	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CA2—glaucoma	5.15e-05	0.000198	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—BAD—glaucoma	5.13e-05	0.000197	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—BAD—glaucoma	5.11e-05	0.000197	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—TXN—glaucoma	5.02e-05	0.000193	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CDKN1B—glaucoma	5.01e-05	0.000193	CbGpPWpGaD
Sirolimus—MTOR—eye—glaucoma	5.01e-05	0.0939	CbGeAlD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.99e-05	0.000192	CbGpPWpGaD
Sirolimus—MTOR—retina—glaucoma	4.96e-05	0.093	CbGeAlD
Sirolimus—FGF2—Signaling Pathways—NTRK2—glaucoma	4.96e-05	0.000191	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.94e-05	0.00019	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—FN1—glaucoma	4.94e-05	0.00019	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CDKN2B—glaucoma	4.92e-05	0.000189	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—BAD—glaucoma	4.88e-05	0.000188	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—GSTM1—glaucoma	4.87e-05	0.000187	CbGpPWpGaD
Sirolimus—FGF2—Immune System—C3—glaucoma	4.83e-05	0.000186	CbGpPWpGaD
Sirolimus—MTOR—connective tissue—glaucoma	4.83e-05	0.0904	CbGeAlD
Sirolimus—FGF2—Adaptive Immune System—CDKN1B—glaucoma	4.82e-05	0.000185	CbGpPWpGaD
Sirolimus—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	4.8e-05	0.000185	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—VEGFA—glaucoma	4.72e-05	0.000182	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—EDN1—glaucoma	4.72e-05	0.000182	CbGpPWpGaD
Sirolimus—FGF2—Immune System—BCL2L1—glaucoma	4.63e-05	0.000178	CbGpPWpGaD
Sirolimus—FKBP1A—eye—glaucoma	4.51e-05	0.0844	CbGeAlD
Sirolimus—FKBP1A—retina—glaucoma	4.46e-05	0.0837	CbGeAlD
Sirolimus—FGF2—Disease—MTHFR—glaucoma	4.46e-05	0.000172	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—TP53—glaucoma	4.37e-05	0.000168	CbGpPWpGaD
Sirolimus—FKBP1A—connective tissue—glaucoma	4.34e-05	0.0813	CbGeAlD
Sirolimus—FKBP1A—Signaling Pathways—NGF—glaucoma	4.34e-05	0.000167	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NGFR—glaucoma	4.26e-05	0.000164	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CA1—glaucoma	4.25e-05	0.000163	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—GSTT1—glaucoma	4.24e-05	0.000163	CbGpPWpGaD
Sirolimus—FGF2—Immune System—BAD—glaucoma	4.19e-05	0.000161	CbGpPWpGaD
Sirolimus—FGF2—Disease—APOE—glaucoma	4.15e-05	0.00016	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—C3—glaucoma	4.12e-05	0.000159	CbGpPWpGaD
Sirolimus—FGF2—Disease—CAV1—glaucoma	4.12e-05	0.000158	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CTSA—glaucoma	4.11e-05	0.000158	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—NOS3—glaucoma	4.11e-05	0.000158	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	4.1e-05	0.000158	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL1A—glaucoma	4.08e-05	0.000157	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—TNF—glaucoma	4.05e-05	0.000156	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NTRK1—glaucoma	4.05e-05	0.000156	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SMO—glaucoma	4.03e-05	0.000155	CbGpPWpGaD
Sirolimus—MTOR—Disease—CDKN2B—glaucoma	3.95e-05	0.000152	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—NOS3—glaucoma	3.92e-05	0.000151	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—GSTT1—glaucoma	3.89e-05	0.00015	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CA2—glaucoma	3.88e-05	0.000149	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.88e-05	0.000149	CbGpPWpGaD
Sirolimus—SLC47A1—eye—glaucoma	3.87e-05	0.0726	CbGeAlD
Sirolimus—FGF2—Disease—BAD—glaucoma	3.87e-05	0.000149	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—APOE—glaucoma	3.84e-05	0.000148	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CAV1—glaucoma	3.8e-05	0.000146	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—PTGS2—glaucoma	3.76e-05	0.000145	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CDKN2B—glaucoma	3.73e-05	0.000143	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CDKN1B—glaucoma	3.72e-05	0.000143	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NTRK2—glaucoma	3.68e-05	0.000142	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—TXN—glaucoma	3.63e-05	0.000139	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—FN1—glaucoma	3.62e-05	0.000139	CbGpPWpGaD
Sirolimus—MTOR—Immune System—C3—glaucoma	3.59e-05	0.000138	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—EDN1—glaucoma	3.58e-05	0.000138	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—BAD—glaucoma	3.58e-05	0.000138	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CDKN1B—glaucoma	3.57e-05	0.000137	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—CDKN1B—glaucoma	3.56e-05	0.000137	CbGpPWpGaD
Sirolimus—MTOR—Immune System—BCL2L1—glaucoma	3.43e-05	0.000132	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.42e-05	0.000131	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CDKN1B—glaucoma	3.4e-05	0.000131	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ABCA1—glaucoma	3.38e-05	0.00013	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CYP1B1—glaucoma	3.38e-05	0.00013	CbGpPWpGaD
Sirolimus—MTOR—Disease—MTHFR—glaucoma	3.31e-05	0.000127	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NGF—glaucoma	3.29e-05	0.000126	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.23e-05	0.000124	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NGFR—glaucoma	3.16e-05	0.000122	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—MMP9—glaucoma	3.15e-05	0.000121	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—C3—glaucoma	3.13e-05	0.00012	CbGpPWpGaD
Sirolimus—FGF2—Disease—NOS3—glaucoma	3.11e-05	0.00012	CbGpPWpGaD
Sirolimus—MTOR—Immune System—BAD—glaucoma	3.11e-05	0.00012	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ABCA1—glaucoma	3.1e-05	0.000119	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CYP1B1—glaucoma	3.1e-05	0.000119	CbGpPWpGaD
Sirolimus—MTOR—Disease—APOE—glaucoma	3.08e-05	0.000119	CbGpPWpGaD
Sirolimus—MTOR—Disease—CAV1—glaucoma	3.06e-05	0.000118	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NTRK1—glaucoma	3e-05	0.000116	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CDKN1B—glaucoma	2.92e-05	0.000112	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—APOE—glaucoma	2.91e-05	0.000112	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CAV1—glaucoma	2.88e-05	0.000111	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NOS3—glaucoma	2.88e-05	0.000111	CbGpPWpGaD
Sirolimus—MTOR—Disease—BAD—glaucoma	2.87e-05	0.000111	CbGpPWpGaD
Sirolimus—FGF2—Disease—PTGS2—glaucoma	2.85e-05	0.00011	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—VEGFA—glaucoma	2.83e-05	0.000109	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GSTT1—glaucoma	2.81e-05	0.000108	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CDKN2B—glaucoma	2.77e-05	0.000106	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.77e-05	0.000106	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—FN1—glaucoma	2.74e-05	0.000106	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—TXN—glaucoma	2.74e-05	0.000105	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—BAD—glaucoma	2.71e-05	0.000104	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—GSTM1—glaucoma	2.7e-05	0.000104	CbGpPWpGaD
Sirolimus—FGF2—Disease—CDKN1B—glaucoma	2.7e-05	0.000104	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—EDN1—glaucoma	2.65e-05	0.000102	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CA1—glaucoma	2.62e-05	0.000101	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CTSA—glaucoma	2.53e-05	9.75e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CDKN1B—glaucoma	2.49e-05	9.59e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—GSTM1—glaucoma	2.48e-05	9.53e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NGF—glaucoma	2.44e-05	9.39e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.44e-05	9.38e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CA2—glaucoma	2.39e-05	9.2e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—MTHFR—glaucoma	2.39e-05	9.18e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—C3—glaucoma	2.32e-05	8.92e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—NOS3—glaucoma	2.31e-05	8.89e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MMP9—glaucoma	2.31e-05	8.88e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ABCA1—glaucoma	2.24e-05	8.62e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CYP1B1—glaucoma	2.24e-05	8.62e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—APOE—glaucoma	2.22e-05	8.54e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CAV1—glaucoma	2.2e-05	8.47e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—MTHFR—glaucoma	2.19e-05	8.42e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NOS3—glaucoma	2.18e-05	8.39e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CDKN1B—glaucoma	2.17e-05	8.34e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—APOE—glaucoma	2.16e-05	8.31e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CAV1—glaucoma	2.14e-05	8.23e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TP53—glaucoma	2.13e-05	8.21e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GSTT1—glaucoma	2.12e-05	8.16e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—PTGS2—glaucoma	2.11e-05	8.13e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—VEGFA—glaucoma	2.07e-05	7.97e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—APOE—glaucoma	2.04e-05	7.84e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—FN1—glaucoma	2.04e-05	7.83e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CAV1—glaucoma	2.02e-05	7.77e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—BAD—glaucoma	2.01e-05	7.74e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—CDKN1B—glaucoma	2e-05	7.7e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CDKN1B—glaucoma	1.89e-05	7.26e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GSTM1—glaucoma	1.79e-05	6.89e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MMP9—glaucoma	1.75e-05	6.73e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ABCA1—glaucoma	1.69e-05	6.5e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CYP1B1—glaucoma	1.69e-05	6.5e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—TXN—glaucoma	1.69e-05	6.48e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—NOS3—glaucoma	1.66e-05	6.4e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NOS3—glaucoma	1.62e-05	6.22e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—MTHFR—glaucoma	1.58e-05	6.09e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—VEGFA—glaucoma	1.57e-05	6.04e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TP53—glaucoma	1.57e-05	6.02e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—NOS3—glaucoma	1.53e-05	5.87e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PTGS2—glaucoma	1.52e-05	5.85e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—APOE—glaucoma	1.47e-05	5.67e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CAV1—glaucoma	1.46e-05	5.62e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CDKN1B—glaucoma	1.4e-05	5.39e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PTGS2—glaucoma	1.4e-05	5.37e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GSTM1—glaucoma	1.35e-05	5.2e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GSTT1—glaucoma	1.31e-05	5.03e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MMP9—glaucoma	1.3e-05	4.99e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—MTHFR—glaucoma	1.19e-05	4.59e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TP53—glaucoma	1.19e-05	4.57e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—VEGFA—glaucoma	1.17e-05	4.48e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—APOE—glaucoma	1.11e-05	4.28e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—NOS3—glaucoma	1.1e-05	4.25e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CAV1—glaucoma	1.1e-05	4.24e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CYP1B1—glaucoma	1.04e-05	4.01e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ABCA1—glaucoma	1.04e-05	4.01e-05	CbGpPWpGaD
Sirolimus—ABCB1—retina—glaucoma	1.03e-05	0.0194	CbGeAlD
Sirolimus—CYP3A5—Metabolism—PTGS2—glaucoma	1.01e-05	3.88e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TP53—glaucoma	8.81e-06	3.39e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—NOS3—glaucoma	8.33e-06	3.2e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GSTM1—glaucoma	8.32e-06	3.2e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGS2—glaucoma	7.62e-06	2.93e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—MTHFR—glaucoma	7.36e-06	2.83e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—APOE—glaucoma	6.85e-06	2.64e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CAV1—glaucoma	6.79e-06	2.61e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—NOS3—glaucoma	5.13e-06	1.97e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGS2—glaucoma	4.69e-06	1.81e-05	CbGpPWpGaD
